Panostaja Oyj
17.3.2021 15:46:54 CET | Globenewswire | Press release
Panostaja Oyj Managers' Transactions
Panostaja Oyj Stock Exchange Bulletin, Managers´ Transactions March 17, 2021 at 16:45 pm.
| Person subject to the notification requirement | ||
| Name: | Pääkkönen, Tarja | |
| Position: | Member of the Board/Deputy member | |
| Initial Notification | ||
| Reference number: | 743700ZGH7GD27UOQO12_20210317122434_31 | |
| Issuer | ||
| Name: | Panostaja Oyj | |
| LEI: | 743700ZGH7GD27UOQO12 | |
| Transaction details | ||
| Transaction date: | 2021-03-17 | |
| Venue: | NASDAQ HELSINKI LTD (XHEL) | |
| Nature of the transaction: | Receipt of a Share-Based Incentive or Remuneration | |
| Instrument: | Share | |
| ISIN: | FI0009800379 | |
| Volume: | 2703 | |
| Unit price: | 0,00000 Euro | |
| Aggregated transactions | ||
| Volume: | 2703 | |
| Volume weighted average price: | 0.00000 Euro | |
PANOSTAJA OYJ
For further information, contact CEO Tapio Tommila: tel. +358 (0)40-527 6311
www.panostaja.fi/en/
To view this piece of content from ml-eu.globenewswire.com, please give your consent at the top of this page.
About Globenewswire
Subscribe to releases from Globenewswire
Subscribe to all the latest releases from Globenewswire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Globenewswire
VIVUS B.V.18.3.2026 14:00:00 CET | Press release
VIVUS Confirms QSIVA® Price Reduction Is Now Effective Across Nordics and Poland
Danmarks Skibskredit A/S18.3.2026 13:44:54 CET | Press release
Proceedings of the Annual General Meeting 2026 of Danish Ship Finance A/S
WallabyPhenox18.3.2026 13:30:00 CET | Press release
WallabyPhenox Restructures Debt and Accelerates Global Growth
Pharma Equity Group A/S18.3.2026 13:24:00 CET | Press release
UPDATE OF THE FINANCIAL CALENDAR FOR 2026
Pharma Equity Group A/S18.3.2026 13:24:00 CET | Pressemeddelelse
OPDATERING AF FINANSKALENDER FOR 2026
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom